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Abstract
DNMT1 is recruited to substrate sites by PCNA and UHRF1 to maintain DNA methylation after replication. The cell cycle
dependent recruitment of DNMT1 is mediated by the PCNA-binding domain (PBD) and the targeting sequence (TS) within the
N-terminal regulatory domain. The TS domain was found to be mutated in patients suffering from hereditary sensory and
autonomic neuropathies with dementia and hearing loss (HSANIE) and autosomal dominant cerebellar ataxia deafness and
narcolepsy (ADCA-DN) and is associated with global hypomethylation and site specific hypermethylation. With functional
complementation assays in mouse embryonic stem cells, we showed that DNMT1 mutations P496Y and Y500C identified in
HSANIE patients not only impair DNMT1 heterochromatin association, but also UHRF1 interaction resulting in hypomethyla-
tion. Similar DNA methylation defects were observed when DNMT1 interacting domains in UHRF1, the UBL and the SRA do-
main, were deleted. With cell-based assays, we could show that HSANIE associated mutations perturb DNMT1 heterochroma-
tin association and catalytic complex formation at methylation sites and decrease protein stability in late S and G2 phase. To
investigate the neuronal phenotype of HSANIE mutations, we performed DNMT1 rescue assays and could show that cells ex-
pressing mutated DNMT1 were prone to apoptosis and failed to differentiate into neuronal lineage. Our results provide in-
sights into the molecular basis of DNMT1 dysfunction in HSANIE patients and emphasize the importance of the TS domain in
the regulation of DNA methylation in pluripotent and differentiating cells.
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Introduction
Epigenetic mechanisms are crucial for the regulation of gene ex-
pression during embryonic development and cell differenti-
ation. Tissue-specific DNA methylation patterns are established
during embryogenesis by the de novo DNA methyltransferases
DNMT3A and DNMT3B, whereas the propagation of these marks
to future somatic cell generations is based on the maintenance
DNA methyltransferase 1 (DNMT1) (1–5). The catalytic activity
of DNMT1 is attributed to its C-terminal domain (CTD), however
enzyme regulation, targeting and activation are mediated by
the N-terminal domain (NTD) harboring distinct subdomains
(6). During S phase DNMT1 localization at sites of DNA replica-
tion is mediated by the PCNA-binding domain (PBD) while het-
erochromatin binding during late S and G2 is mediated by the
targeting sequence (TS) domain, both of which contribute to
proper maintenance of DNA methylation patterns (7–9).
A key factor in the regulation of DNMT1 is Ubiquitin-like, con-
taining PHD and RING finger domains 1 (UHRF1, also known as
95 kDa mouse nuclear protein (Np95)). By binding to hemimethy-
lated DNA via its SET and RING associated (SRA) domain (10–14),
UHRF1 targets DNMT1 to its substrate sites (10). In addition,
UHRF1 binds to methylated H3K9 via its tandem Tudor domain
(TTD) and to H3R2 via its plant homeodomain (PHD) (15–18).
By cooperative binding of repressive H3K9me3 marks and
hemimethylated DNA, UHRF1 targets DNMT1 to newly synthe-
sized DNA in heterochromatin after replication (19). In addition,
the UHRF1 RING domain ubiquitinates H3 tails on K18 (K23 in
Xenopus), which is specifically recognized by the ubiquitin
interacting motif (UIM) in the TS domain of DNMT1 and
required for DNA methylation (20,21). Besides intermolecular
protein–protein binding, also intramolecular protein inter-
actions serve as a prerequisite for DNMT1 activation. Firstly, in
complex with unmethylated DNA, the linker between the zinc
finger (CXXC) domain and the bromo-adjacent homology do-
main 1 (BAH1) blocks the access of DNA to the catalytic center
(22). Secondly, the crystal structure of DNMT1 reveals that, in
absence of DNA, the TS domain is inserted in the DNA-binding
pocket of the CTD thereby inhibiting enzymatic activity (23).
These two autoinhibitory mechanisms have to be overcome by
structural changes before the methylation reaction can occur.
Interaction of UHRF1 with DNMT1 releases the TS domain and
enables catalytic activity of the CTD (24).
In addition to enzyme targeting and activation, protein stabil-
ity also contributes to the regulation of maintenance DNA methy-
lation. Stability and abundance of DNMT1 during the cell cycle is
governed by UHRF1 dependent ubiquitination and deubiquitina-
tion by the ubiquitin specific peptidase 7 (USP7, also known as
herpes virus associated ubiquitin specific protease (HAUSP))
which protects against proteasomal degradation (25,26). While
Tip60 mediated acetylation promotes ubiquitination by UHRF1
and thereby marks DNMT1 for proteasomal degradation, the cor-
responding deacetylation by histone deacetylase 1 (HDAC1) con-
tributes to the stabilization of DNMT1 (25,26).
Despite its well-known replication-coupled function as main-
tenance DNA methyltransferase in proliferating cells, DNMT1 is
highly expressed in embryonic and adult postmitotic neurons, es-
pecially in the central nervous system (CNS) (27,28). Remarkably,
DNA methylation is required in adult neurogenesis and its misre-
gulation was described to be involved in the pathophysiology of
neurodegenerative disorders (29,30). Several medical studies have
reported heterozygous DNMT1 mutations causing DNA hypome-
thylation in patients suffering from hereditary sensory and auto-
nomic neuropathy type IE (HSANIE, OMIM 614116) or autosomal
dominant cerebellar ataxia deafness and narcolepsy (ADCA-DN,
OMIM 604121). Strikingly, all causative mutations described to
date affect a genomic region in DNMT1, which codes for the TS
domain (31–38). Clinical manifestations of HSANIE and ADCA-DN
include a broad phenotypic spectrum with sensory impairment,
hearing loss and dementia as hallmarks of the disease (38). In
particular, HSANIE is characterized by late onset neurologic dis-
orders of the CNS and the peripheral nervous system that mani-
fest in progressive degeneration predominantly of sensory and
autonomic neurons (39). However, the pathophysiological trajec-
tories underlying these neurological disorders caused by DNMT1
mutations remain mostly unknown.
In this study, we investigate the effect of DNMT1 mutations
identified in HSANIE patients on the function of the TS domain
in embryonic stem cells and neuronal progenitor cell differenti-
ation. With functional complementation assays, we show that
HSANIE associated mutations in mouse DNMT1 disrupt binding
of UHRF1 and lead to defects in maintenance DNA methylation.
We show that the TS point mutations affect the association
with late replicating chromatin, catalytic complex formation at
methylation sites and cell cycle dependent protein stability.
Importantly, ESCs expressing HSANIE mutants fail to differ-
entiate into the neuronal lineage and are prone to undergo
apoptosis. These results emphasize the importance of the com-
plex interplay of UHRF1 with the TS domain in regulating
DNMT1 function and DNA methylation in neurogenesis.
Results
Deletions and TS domain mutations found in HSANIE
patients affect DNMT1 activity in vivo
Although the catalytic activity of DNMT1 resides in its CTD, the
NTD of the enzyme is indispensable for proper maintenance DNA
methylation (6). Within the NTD the TS domain spans from amino
acid 309 to 628 in mouse isoform 2 and is highly conserved among
different species (Fig. 1). To map regions required for methylation
activity, we generated a systematic set of DNMT1 deletion con-
structs and performed rescue experiments expressing the deletion
constructs in Dnmt1/ mouse embryonic stem cells (ESCs). Site
specific DNA methylation analysis revealed that not only the re-
gions between amino acid (aa) 356 to 404 and 458 to 500 (21), but
also regions from 496 to 573 are functionally relevant to maintain
methylation patterns at pericentromeric heterochromatin (Fig. 2A,
shown in dark blue). DNMT1 either lacking the flexible, less con-
served N-terminal region of the TS domain (aa 309 to 355), or the C-
terminal region of the TS domain (aa 579 to 595) was able to restore
methylation at major satellite repeats (Fig. 2A, shown in light blue).
Interestingly, mutations of two highly conserved amino acids
in the TS domain (Fig. 1B) were linked to a neurodegenerative
disease described as HSANIE (31,39). As the HSANIE associated
mutations are located within a functionally relevant central re-
gion of the TS domain (Fig. 2A), we investigated the DNA methy-
lation activity of GFP-DNMT1 harboring HSANIE mutations. To
this end, we cloned HSANIE associated mutations P496Y
(human: D490E.P491Y) and Y500C (human: Y495C) in mouse
DNMT1 expression constructs and reintroduced the mutant pro-
teins in Dnmt1/ ESCs (Supplementary Material, Fig. S6). In line
with previous findings (31), we found that transiently and stably
expressed mutated DNMT1 is unable to rescue DNA methylation
levels in vivo (Fig. 2B, Supplementary Material, Fig. S1A and S1C).
Methylation levels at imprinted and unmethylated H19 pro-
moter remained unchanged (Supplementary Material, Fig. S1B).
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To investigate a potential targeting defect of DNMT1 harboring
HSANIE associated mutations, we made use of a DNA methyl-
transferase trapping assay in living cells. In this assay, the cyto-
sine analogue 5-aza-20-deoxycytidine (5-aza-dC) is incorporated
into DNA during replication and forms an irreversible covalent
complex with the active methyltransferase at the C6 position of
the cytosine residue thereby immobilizing the catalytically active
enzyme at DNA replication foci (40). Trapping was measured by
fluorescence recovery after photobleaching (FRAP). We found that
DNMT1 harboring HSANIE mutations can be trapped, but exhibit a
larger mobile fraction than DNMT1 wild-type (wt) indicating a
lower targeting to substrate sites in living cells (Fig. 2C). In
summary, we could show that the TS domain of DNMT1 is essen-
tial for maintenance DNA methylation. Deletions in the TS do-
main between amino acid 356 to 573 as well as point mutations
found in HSANIE patients lead to decreased methylation activity
in vivo.
Functional relevance of UHRF1 domains on the
regulation of DNMT1 enzymatic activity
UHRF1 is required for maintaining DNA methylation patterns
after replication by direct interaction with DNMT1 (10). To eluci-
date which protein domains are involved in the interaction of
Figure 1. Domain structure of mouse DNMT1 and conservation of the TS domain among different species. (A) Domain structure of GFP-DNA methyltransferase 1 (DNMT1) with
illustration of deletions and HSANIE associated point mutations in the targeting sequence (TS) domain. The large regulatory N-terminal domain (NTD) of DNMT1 is comprised of
a DNA methyltransferase associated protein 1 (DMAP1)-binding domain, a proliferating cell nuclear antigen (PCNA)-binding domain (PBD), the TS domain harboring a ubiquitin
interacting motif (UIM (21)), a zinc finger (CXXC) domain, two bromo-adjacent homology (BAH1 and BAH2) domains and a catalytically active C-terminal domain (CTD). (B)
Primary sequence alignment of TS domains from different species. The secondary structure of the mouse TS domain is indicated (PDB: 3AV4 (23)). Highly conserved residues are
shaded black. Deleted regions are indicated by blue rectangles and hereditary sensory and autonomic neuropathy type IE (HSANIE) associated point mutations by red arrows.
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DNMT1 and UHRF1 (Fig. 3A), we generated a systematic set of
constructs of the NTD and CTD of DNMT1 as well as single do-
mains of UHRF1 and performed a binding assay. We used a
semi-quantitative fluorescence protein–protein interaction
assay, in which GFP-tagged proteins are immobilized on a GFP-
multiTrap plate, incubated with RFP/Ch-tagged proteins and
binding ratios are determined by fluorescence readout (41).
Mapping studies on UHRF1 showed that the SRA domain inter-
acted with DNMT1 (Fig. 3C). In terms of DNMT1, the TS medi-
ated the binding to UHRF1 (Fig. 3B). To analyze domain
contribution to the TS domain interaction in the UHRF1 protein
context, we tested the binding of Ch-TS to UHRF1-GFP single do-
main deletions (Fig. 3D). We generated constructs with single
domain deletions of UHRF1 and found that deletions of the
TTD, the PHD and the RING domain had little to no effect on the
interaction, whereas deletions of the UBL and the SRA domain
reduced the binding of Ch-TS to UHRF1-GFP indicating that the
TS domain of DNMT1 can interact with two domains of UHRF1,
the UBL and the SRA domain of UHRF1 (Fig. 3F). In our experi-
mental set-up, the UBL domain alone, however, did not interact
with DNMT1 suggesting a cooperative binding mode involving
the UBL and SRA domain of UHRF1.
To examine which domains of UHRF1 are functionally rele-
vant for regulation of DNMT1 enzymatic activity, we
investigated the ability of UHRF1 single domain deletions in
mediating DNA methylation in vivo. All Uhrf1/ ESC lines stably
expressing UHRF1-GFP with single domain deletions displayed
low methylation levels suggesting a DNMT1 recruitment defect
(Fig. 3E). Consequently, we investigated the dependence of
DNMT1 subnuclear localization on UHRF1 domains. In the wt
UHRF1-GFP cell line, DNMT1 showed late S phase-specific het-
erochromatin association that was abolished in all single do-
main UHRF1 deletion cell lines displaying diffuse nuclear
localization of DNMT1 comparable to Uhrf1/ ESCs
(Supplementary Material, Figs S3 and S4). In conclusion, all
UHRF1 domains are required for recruitment of DNMT1 for
maintenance DNA methylation.
HSANIE associated mutations in TS domain of DNMT1
affect the interaction with UHRF1 and lead to
dissociation from heterochromatin
As HSANIE associated mutations in the TS domain of DNMT1
lead to hypomethylation at pericentric heterochromatin and
the TS mediates the interaction with UHRF1, we investigated
the effects of HSANIE mutations on UHRF1 interaction. With
coimmunoprecipitation experiments, we found that mutated
TS was defective in binding UHRF1 (Fig. 4A), which was
Figure 2. TS domain deletions and HSANIE associated mutations affect the DNA methylation activity of DNMT1 in vivo. (A and B) Site-specific DNA methylation analysis
at major satellite repeats of mouse Dnmt1/ ESCs expressing transiently GFP-DNMT1 wild-type (wt) and deletions (A) or HSANIE associated point mutant constructs
(B). DNA methylation levels of untransfected Dnmt1/ ESCs are displayed for comparison. Shown are mean values6 standard deviations (SDs) from two to six (A) or
(B) three independent biological replicates (average from eight CpG sites, respectively). (B) Two-sample t-tests were performed that assume equal variances. Asterisks
represent significant differences: *P<0.05, **P< 0.001. (C) Quantitative evaluation of FRAP data showing mean curves. Error bars represent standard deviations. FRAP of
S-phase mouse embryonic fibroblasts (n¼5) expressing GFP-DNMT1 and GFP-DNMT1 harboring HSANIE mutations without drug treatment (upper panel) and after
treatment with 30 mM 5-aza-dC for 30 min (lower panel).
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Figure 3. DNMT1 TS domain interaction with UHRF1 is necessary for DNA methylation. (A) Schematic outline of DNMT1 and the ubiquitin-like, containing PHD and
RING finger domains 1 (UHRF1) expression constructs used for protein–protein interaction mapping studies. UHRF1 harbors an ubiquitin-like domain (UBL) followed by
a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET and RING associated (SRA) domain and a really interesting new gene (RING) domain. (B) Mapping
and relative quantification of the interaction GFP-DNMT1 with Ch-UHRF1 by fluorescence protein–protein interaction assay in vitro. Ratios of Ch-UHRF1 over GFP fusion
proteins are shown as mean values6 standard error of the mean (SEM) of three to six biological replicates. (C) Mapping and relative quantification of the interaction
GFP-UHRF1 with RFP-DNMT1 by fluorescence protein–protein interaction assay in vitro. Ratios of RFP-DNMT1 over GFP fusion proteins are shown as mean
values6SEM of three biological replicates normalized to the binding ratio of the GFP-UHRF1 full length protein. (D) Schematic outline of different UHRF1-GFP single do-
main deletion (D) constructs used for rescue experiments. (E) Local methylation analysis at major satellite repeats. CpG methylation levels in Uhrf1/ ESCs stably ex-
pressing UHRF1-GFP wt or single domain deletions were analyzed. DNA methylation levels of untransfected Uhrf1/ ESCs are shown for comparison. Values represent
means from eight CpG sites. (F) Coimmunoprecipitation of UHRF1-GFP wt and single domain deletion mutants and Ch-TS. GFP and Ch fusion constructs were coex-
pressed in HEK293T cells and cell lysates were used for immunoprecipitation with the GFP-Trap. Bound fractions were detected by immunoblotting with anti-GFP and
anti-Ch antibodies. GFP was used as negative control. I¼ Input, B¼Bound.
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confirmed by a semiquantitative fluorescence protein–protein
interaction assay (Fig. 4B). Expression of GFP-TS in ESCs re-
vealed that while the TS domain was tightly associated with
heterochromatin in wt cells, enrichment of the TS domain at
chromocenters was lost and the signal was diffusely distributed
in the nucleus in UHRF1 depleted cells (Uhrf1/) (Fig. 4C). A
similar delocalization was found in UHRF1 binding deficient TS
domain mutants (Fig. 4D, Supplementary Material, Fig. S5). With
half nucleus FRAP we investigated the mobility of TS domain fu-
sions in MEFs and found that HSANIE mutations caused fast
protein mobility indicating chromatin binding defects (Fig. 4E).
Notably, the interaction of DNMT1 with the replication protein
PCNA was not altered by the HSANIE mutations arguing against
severe misfolding of the mutant proteins (Supplementary
Figure 4. HSANIE associated point mutations in the TS domain reduce the interaction of DNMT1 with UHRF1. (A) Coimmunoprecipitation of GFP-TS wt, P496Y, Y500C
and P496Y.Y500C mutant constructs and Ch-UHRF1. GFP and Ch fusion constructs were coexpressed in HEK293T cells and cell lysates were used for immunoprecipita-
tion with the GFP-Trap. Bound fractions were analyzed by immunoblotting with anti-GFP and anti-Ch antibodies. GFP was used as negative control. I¼ Input,
B¼Bound. (B) Fluorescence protein–protein interaction assay of the GFP-DNMT1 NTD with Ch-UHRF1. After one-step purification of the GFP-DNMT1 NTD wt and mu-
tant constructs in a GFP-multiTrap plate, the binding of Ch-UHRF1 expressed in HEK293T cells was determined by fluorescence readout. GFP and RFP were used as
negative control. Shown are mean relative binding ratios6SEM of Ch-UHRF1 or RFP over GFP fusion proteins from four to six biological replicates. Two-sample t-tests
were performed that assume equal variances. Significance compared to the relative binding ratio of GFP-DNMT1 NTD wt are indicated: *P<0.05, **P<0.001.
(C) Confocal midsections of fixed mouse ESCs (wt, Uhrf1/) transiently expressing GFP-TS and DNA was counterstained with DAPI. In the merged image, DAPI is de-
picted in magenta. Scale bar 10 mm; enlargements: 3-times magnification, scale bar 2 mm. (D) Confocal midsections of fixed MEF cells transfected with GFP-TS wt or
GFP-TS Y500C and P496Y.Y500C constructs. In the merged image, GFP-TS is depicted in red and DAPI in magenta. Scale bar 5 mm; enlargements: 3-times magnification,
scale bar 1 mm. (E) Protein mobility of GFP-TS wt and HSANIE associated GFP-TS Y500C and P497Y.Y500C mutants in living MEF cells (n¼ 13) determined by half nucleus
fluorescent recovery after photobleaching (FRAP) analysis. Curves represent mean6SEM.
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Material, Fig. S2). In conclusion, our findings suggest that the TS
domain is crucial for mediating the interaction of DNMT1 with
UHRF1 and that this interaction is affected by the HSANIE asso-
ciated mutations located in this region.
The destabilization of HSANIE associated GFP-DNMT1
TS mutants is cell cycle-dependent
As the TS domain is essential for late S phase-specific localiza-
tion and mobility of DNMT1 (42), we tested the effect of HSANIE
mutations on subcellular localization of GFP-DNMT1 on a single
cell level throughout the cell cycle. We imaged living cells coex-
pressing GFP-DNMT1 wt or GFP-DNMT1 P496Y.Y500C with RFP-
PCNA as a cell cycle marker. While the localization in early to
mid S phase was comparable to wt, the GFP signal of mutant
DNMT1 dropped when cells entered late S phase. In addition,
the double point mutant displayed only weak late S phase-
specific association with heterochromatin and did not display
the characteristic, prolonged TS domain mediated heterochro-
matin association in G2 (Fig. 5A). Interestingly, the signal of
GFP-DNMT1 P496Y.Y500C recovered in G1 phase indicating a
cell cycle dependency of this defect (Fig. 5B). To investigate a po-
tential stability defect of mutant DNMT1, we performed cyclo-
heximide experiments, which showed that GFP-DNMT1
abundance and stability was reduced by the HSANIE mutations
(P496Y, Y500C or P496Y.Y500C) (Supplementary Material, Fig.
S6). These results provide evidence for a cell cycle-dependent
destabilization of GFP-DNMT1 harboring HSANIE mutations be-
ginning in late S phase that might be caused by insufficient tar-
geting to late replicating heterochromatin.
Figure 5. The destabilization of the DNMT1 HSANIE associated mutations is cell cycle dependent. (A and B) Spinning disk confocal midsections of MEF cells transiently
coexpressing GFP-DNMT1 wt or P496Y.Y500C mutant and RFP-PCNA as a cell cycle marker. (A) Selected frames from live cell series are shown of GFP-DNMT1 wt (left
panel) and GFP-DNMT1 P496Y.Y500C (right panel). Cells were tracked starting from early S until G2 phase. In the merged image, RFP-PCNA is depicted in magenta.
(B) Live cell series of MEF cells shown in (A) transiently coexpressing GFP-DNMT1 wt (upper panel) or P496Y.Y500C (lower panel). Starting from very late S phase (wt) or
mid S phase (P496Y.Y500C) images were taken every 200 min. White represents the highest and black the lowest intensity. Scale bar 5 mm.
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HSANIE associated point mutations affect neuronal
progenitor differentiation
As HSANIE associated mutations in DNMT1 lead to a neuronal
restricted phenotype in HSANIE patients (31), we investigated
the potential of cells expressing DNMT1 with HSANIE associated
mutations to differentiate into the neuronal lineage. During
neuronal progenitor cell (NPC) differentiation (Fig. 6A), we
examined cell viability of wt, Dnmt1/ and different ESC lines
carrying HSANIE associated mutations (Supplementary
Material, Fig. S7). In the pluripotent state and on day 8 of differ-
entiation (Supplementary Material, Fig. S8), wt, Dnmt1/ and
mutant cell lines exhibited a similar viability degree. Strikingly,
young neuronal progenitors generated from Dnmt1/ cells, as
well as stably expressing GFP-DNMT1 Y500C and double mu-
tants P496Y.Y500C did not fully develop into differentiated
NPCs, but instead were prone to undergo apoptosis 2 h after dis-
sociation from cellular aggregates (Fig. 6B). Furthermore, we
compared mRNA expression levels in NPCs of pluripotency
gene Oct4 and Brachyury, Gata6 and Nestin for early mesodermal,
primitive endodermal and ectodermal lineage, respectively.
GFP-DNMT1 Y500C and double mutant P496Y.Y500C NPCs had
lower expression levels of developmental marker Nestin, a
marker for neuronal progenitor differentiation and elevated ex-
pression levels of pluripotency marker Oct4 indicating an un-
completed differentiation in NPCs (Fig. 6C). The results
highlight the importance of proper DNMT1 function during
neurogenesis and indicate that the limited differentiation po-
tential of DNMT1 deficient cells cannot be rescued by DNMT1
harboring HSANIE associated mutations.
Discussion
For long, DNA methylation has been regarded as a stable epi-
genetic mark set by the de novo DNA methyltransferases
DNMT3A and DNMT3B during development and maintained
after each round of DNA replication by DNMT1 (1–5). This sim-
ple view of DNA methylation, however, cannot explain why
DNMT1 is expressed and required in postmitotic cells (27,28).
Despite or because of the central and ubiquitous role in DNA
methylation only very few human diseases were linked to het-
erozygous DNMT1 mutations that are mostly restricted to the
TS domain within the regulatory NTD of DNMT1 (43). So far, two
neurodegenerative diseases HSANIE and ADCA-DN have been
linked to mutations in the TS domain of DNMT1 (31,32) but the
underlying molecular mechanism remained elusive.
To investigate how simple amino acid exchanges outside
the catalytic domain of DNMT1 may lead to global hypomethy-
lation and neurodegenerative diseases, we transferred these
mutations to a controlled ESC differentiation system and
assayed for cellular defects. As UHRF1 plays a central role in the
regulation of DNMT1, we first investigated whether the HSANIE
mutations affect this interaction. Our coimmunoprecipitation
experiments and deletion analyses show an interaction of the
TS domain with the SRA domain of UHRF1, which is consistent
with previous yeast two-hybrid screens (44). Interestingly, the
HSANIE mutations are located within this part of the TS domain
and indeed weaken this protein–protein interaction. We could
demonstrate that mutated DNMT1 showed weaker association
with heterochromatin in late S phase and failed to maintain
DNA methylation in ESC, which is consistent with the previous
Figure 6. HSANIE associated point mutations in the TS domain show different survival rate and differentiation potential during neuronal progenitor differentiation.
(A) Mouse embryonic stem cells are differentiated into young neuronal progenitor cells (NPCs). Scale bar: 200 mm. (B) Flow cytometric analysis of alive, early apoptotic,
late apoptotic and necrotic cells. Two hours after dissociation of cellular aggregates, young neuronal progenitors were analyzed using Annexin V and propidium iodide
staining. Bar graphs represent mean values6 standard deviation (SD) from two to three biological replicates. (C) RNA expression profiles of NPCs in biological dupli-
cates (wt) or triplicates (P496Y, Y500C, P496Y.Y500C) of pluripotency factor Oct4, lineage specific markers Brachyury, Gata6 and Nestin for mesodermal, endodermal and
ectodermal lineage, respectively. All ddCt values are normalized to wt Oct4 expression.
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observation that UHRF1 is required for recruitment of DNMT1
(10). The interaction of UHRF1 with DNMT1 was also shown to
be essential for allosteric activation of the enzyme to enable
binding of substrate DNA to the CTD (23,24,45–47). The weak-
ened interaction could explain the reduced activity of mutated
DNMT1 pull-downs in vitro (31) and fits well with our observa-
tion that DNMT1 harboring HSANIE mutations are impaired in
catalytic complex formation as measured with our trapping
assay in living cells. In addition to defects in enzyme activation
and targeting, we show that HSANIE mutations also cause pro-
teasomal degradation of DNMT1 in late S and G2 phase, likely
as a result of failed heterochromatin binding, which is consist-
ent with previous studies (31). Similar protein destabilization
was shown for chromatin unbound DNMT3A and DNMT3B
(48,49).
Besides harboring a binding site for UHRF1, the TS domain of
DNMT1 also contains a UIM that recognizes H3K18 ubiquiti-
nated by UHRF1 (21). Although this UIM is well separated in pri-
mary and tertiary structure from the sites mutated in HSANIE
patients, allosteric interference with H3K18ub binding cannot
be ruled out. In addition to UHRF1 and histone binding, DNMT1
is subjected to further protein interactions and multiple post-
translational modifications, which likely contribute to proper
regulation of DNA methylation (50). Several of these inter-
actions may not be absolutely required but may enhance local
or global efficiency and thereby contribute to the fine tuning
DNMT1 activity as we found for the interaction with PCNA,
which 2-fold enhances DNMT1 efficiency in living cells (51,52).
While it is unclear which of these interactions are affected by
the HSANIE mutations in different cell types, we could clearly
show that ESCs carrying these mutations are impaired in neur-
onal differentiation and prone to apoptosis.
Curiously, although HSANIE TS domain mutations are pre-
sent in all patient tissues, they mostly affect the neuronal lin-
eage causing both central and peripheral neurodegeneration.
Although it is not clear yet how dynamic the changes in DNA
methylation could be in postmitotic neurons, the turnover and
change of DNA methylation has emerged as one possible modu-
lator of neuronal plasticity in response to external or internal
stimuli (53–55). This fits with the observation that neuronal tis-
sues are characterized by strong expression of ten-eleven trans-
location (TET) genes and high hmC levels (56–59). Therefore,
DNA modification might be more dynamic in postmitotic neu-
rons than previously thought so that even small changes in pro-
tein–protein interactions and activity might unbalance the
equilibrium of DNA modifications. But it remains unclear why
neuronal tissues are specifically affected by these DNMT1 muta-
tions in HSANIE patients.
In summary, we show that HSANIE mutations affect DNMT1
interaction with the essential cofactor UHRF1, cause cell cycle
dependent degradation of DNMT1 and impair neuronal differ-
entiation. These data add to our understanding of the role and
regulation of DNMT1 during differentiation and help to under-
stand DNMT1 dysfunction and hypomethylation in the patho-
genesis of this neurodegenerative disease.
Materials and Methods
Mammalian expression constructs and antibodies
Mouse fusion constructs were generated using enhanced green
fluorescent protein (GFP), monomeric red fluorescent protein
(RFP) or monomeric cherry (Ch). The expression constructs
for RFP-DNMT1, GFP-DNMT1 wt, GFP-DNMT1D356-404, GFP-
DNMT1D458-500, GFP-NTD, Ch-TS, GFP-DNMT1 (1-308), GFP-TS,
GFP-DNMT1 (629-1110) and GFP-CTD have been described previ-
ously (9,21,26,40,60,61). GFP-DNMT1 deletion and HSANIE point
mutants as well as UHRF1-GFP deletion expression constructs
were derived from the corresponding wt constructs by overlap
extension PCR (62). The GFP-UHRF1, UHRF1-GFP, Ch-UHRF1 and
GFP-UHRF1 single domain constructs have been reported before
(17,51,63,64). GFP, RFP and RFP-PCNA have been reported before
(9,25,65,66). All constructs were verified by DNA sequencing.
The following monoclonal antibodies were used for immuno-
blotting: rat anti-RFP/Ch (5F8, Chromotek; (67), rat anti-GFP
(3H9, Chromotek). In dependence on the expected intensity of
the signals, secondary antibodies either conjugated to horserad-
ish peroxidase (HRP) (anti-rat (Dianova)) or conjugated to fluor-
escent dyes (anti-rat Alexa Fluor 488, Alexa Fluor 594 or Alexa
Fluor 647 (Invitrogen)) were applied. For detection of HRP-
conjugated antibodies an ECL Plus reagent (GE Healthcare,
Thermo Scientific) was used.
Cell culture, transfection and immunofluorescence
staining
HEK293T cells were cultured in Dulbecco’s modified Eagle me-
dium supplemented with 10% fetal bovine serum and 50 mg/ml
gentamicin. MEF cells were cultured in Dulbecco’s modified
Eagle medium supplemented with 15% fetal bovine serum, non-
essential amino acids, 2 mM L-glutamine, 0.1 mM b-mercaptoe-
thanol (Gibco-BRL), 100 U/ml penicillin and 100 mg/ml strepto-
mycin (PAA Laboratories GmbH). Mouse ESCs were cultured as
published (51) with the exception that the medium was supple-
mented with 2i inhibitors (1 mM MEK inhibitor PD and 3 mM GSK-
3 inhibitor CHIR) (2i, Axon Medchem) (63). To analyze the DNA
methylation level in stably expressing UHRF1-GFP ESC lines, we
cultured the cell lines in medium supplemented with 1,000 U/
ml recombinant mouse leukemia inhibitory factor LIF
(Millipore). Mouse J1 Dnmt1/ ESCs are homozygous for the c
null allele and have been described before (65). Mouse E14 wt
and Uhrf1/ cells (M. Muto and H. Koseki) as well as J1 triple
knockout cells (Masaki Okano) have been reported previously
(68). HEK293T cells were transfected with polyethylenimine
(Sigma). Mouse ESCs and MEF cells were transfected with
Lipofectamin (Invitrogen). Fixation, DAPI counterstaining and
image acquisition cells was performed as described before (17).
Live cell microscopy, DNAmethyltransferase trapping
assay and fluorescence after photobleaching analysis
Live cell imaging and the trapping assay were performed as
described previously (40,42). Briefly, mouse embryonic fibro-
blasts stably expressing RFP-PCNA were seeded on multi-well
imaging slides (ibidi) and transfected using Lipofectamine 3000
(Life Technologies) following the manufacturer’s protocol.
Trapping assay was performed on an Ultraview-Vox spinning
disk system (Perkin-Elmer) equipped with an EMCCD camera
(Hamamatsu, Japan) a microirradiation system, and an environ-
mental chamber kept at 37 C with 5% CO2, using a 63X 1.4 NA
Plan-Apochromat oil-immersion objective (Zeiss). Imaging was
performed with 488 nm and 561 nm solid-state laser diodes,
using minimal gain and 22 camera binning for a final pixel
size of 220 nm. Cells in late S-phase were visually identified for
photobleaching experiments. For each photobleaching experi-
ment, three pre-bleach images were acquired, before using the
microirradiation system with the 488 nm laser to photobleach a
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small area (<1 mm). After bleaching, images were acquired for
both fluorophores every 10 s for up to 5 min.
Data extraction and FRAP normalization was performed in
Fiji. Briefly, images were background subtracted and registered
to correct for xy drift and cell motion artifacts. ROIs correspond-
ing to the bleached area and to the entire nucleus were manu-
ally selected, and mean fluorescence intensities were extracted
for each timepoint. From these raw intensities, two normaliza-
tion steps were performed. First each data point was normal-
ized to its corresponding average pre-bleach intensity, and then
each data point from the bleached area was normalized to the
total nuclear fluorescence at its corresponding timepoint to cor-
rect for acquisition photobleaching. Normalized recovery data
was then imported into R (69).
Generation of stable ESC lines and DNAmethylation
analysis
Forty-eight hours after transfection with GFP tagged constructs,
GFP positive ESCs were separated using a fluorescence activated
cell sorting (FACS) Aria II instrument (Becton Dikinson) and the
cells were subsequently grown in selective medium containing
10 mg/ml blasticidin (GFP-DNMT1 cell lines) or normal medium
(UHRF1-GFP cell lines). After expansion, cells were again FACS
sorted one or two more times until at least 90% of the popula-
tion was GFP positive. Furthermore, the GFP-DNMT1 cell lines
were single cell sorted and clones with low expression levels
were chosen for further analysis. The GFP-DNMT1 ESC line has
been reported before (26). Genomic DNA isolation, bisulfite con-
version, Primer sets and PCR conditions were described before
(61,70). All PCR products were analyzed by pyrosequencing
(Varionostic).
Neuronal progenitor cell (NPC) differentiation
The differentiation of pluripotent ESCs into NPCs was based on
a protocol described before (71).
Analysis of cell viability
In order to analyze cell viability, we stained apoptotic cells with
annexin V and necrotic cells with propidium iodide. To test the
efficiency of the staining, apoptosis was induced by treatment
of the cells with 5 mM staurosporine for 2 h (‘apoptotic control’)
(Supplementary Material, Fig. S8). For the staining 200,000 cells
were resuspended in 100 ml annexin binding buffer (100 mM
HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). Cells were stained
with 5 ml Alexa Fluor 350 conjugated annexin V (Thermo Fisher)
for 15 min at room temperature protected from light. 400 ml
annexin binding buffer were added and necrotic cells were
stained by addition of 20 lg/ml propidium iodide solution
(Sigma Aldrich) shortly before analysis by flow cytometry using
a FACS Aria II instrument (Becton Dickinson). Quantification of
alive, necrotic, early and late apoptotic cells was performed
using the single cell analysis software FlowJo.
RNA isolation, cDNA synthesis and real-time PCR
Total RNA was isolated from cells using a nucleospin triprep kit
(Macherey-Nagel). 500 ng of total RNA was reverse transcribed
with a high-capacity cDNA reverse transcription kit (Applied
Biosystems) according to the manufacturer’s instructions. Real-
time PCR was conducted using LightCyclerVR 480 SYBR Green I
Master on a LightCyclerVR 480 Instrument II (Roche). PCR effi-
ciency and primer pair specificity was examined using a stand-
ard curve of serially diluted cDNA and melting curve,
respectively. After normalization to the transcript level of glyc-
eraldehyde phosphate dehydrogenase, data were analyzed
based on the 2-DDCT method (72). A detailed list of primers
used in the real-time PCR is shown in Supplementary Material,
Table S1.
Protein–protein interaction assay and
coimmunoprecipitation
For protein–protein interaction assays and coimmunoprecipita-
tion GFP and RFP or Ch fusion constructs were expressed in
HEK293T cells and 2 days after transfection cells were harvested
in ice cold PBS. Cell pellets from one to two 10 cm dishes were
lysed in 200 ml lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA, 0.1 mM MgCl2, 0.1% NP-40, 1protease inhibitor,
2 mM PMSF, 1 mg/ml DNaseI (AppliChem)) and a protein–protein
interaction assay in GFP-multiTrap plates (Chromotek) was
performed as described (41) with the following adaptations: GFP
extracts were equalized to a concentration of 60 nM in immuno-
precipitation buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA) prior to one step purification in blocked (3% milk)
GFP-multiTrap plates. After stringent washing (wash buffer;
20 mM Tris–HCl pH 7.5, 300 mM NaCl, 0.5 mM EDTA), purified
GFP fusion proteins were incubated with crude protein extracts
of RFP or Ch fusion proteins at a concentration of 1.1 to 2.1 mM
diluted in IP buffer (excess of amount RFP or Ch fusion proteins
in relation to GFP fusions: 18–35 times). Bound fractions were
quantified by fluorescence intensity measurements with a
Tecan Infinite M1000 plate reader (Tecan). For coimmunopreci-
pitation assays, the GFP and RFP or Ch fusion constructs were
coexpressed in HEK293T cells, protein extracts were equalized
and depending on the expression amounts of 5–30 pmol GFP-
fusion protein were applied for the coimmunoprecipitation
with the GFP-Trap (Chromotek). Note that the plasmid amount
of GFP fusion construct and RFP fusion constructs used for
transfection was adapted in a way to have at least a 3-fold ex-
cess of the molar RFP or Ch fusion protein amount in relation to
GFP fusions. Bound fractions were firstly detected by fluores-
cence intensity measurements and secondly by immunoblot-
ting using specific antibodies.
Statistical Analysis
Results were depicted as mean values6 standard deviations
(SDs) or as mean values6 standard errors of the mean (SEM)
from the number of biological replicates indicated in the corres-
ponding figure legend. The difference between two mean values
was analyzed by Student’s t-test and was considered as statis-
tically significant in case of P< 0.05 (*) and highly significant for
P< 0.001 (**).
Sequence Alignments
Alignments were prepared using ClustalW2 (73) and ESPript
(74).
Supplementary Material
Supplementary Material is available at HMG online.
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